Abstract:Abstract Tumor drug resistance emerges from the interaction of two critical factors: tumor cellular heterogeneity and the immunosuppressive nature of the tumor microenvironment (TME). Tumor-associated macrophages (TAMs) constitute essential components of the TME. M2-like TAMs are essential in facilitating tumor metastasis as well as augmenting the drug resistance of tumors. This review encapsulates the mechanisms that M2-like TAMs use to promote tumor drug resistance. We also describe the emerging therapeutic strategies that are currently targeting M2-like TAMs in combination with other antitumor drugs, with some still undergoing clinical trial evaluation. Furthermore, we summarize and analyze various existing approaches for developing novel drugs that target M2-like TAMs to overcome tumor resistance, highlighting how targeting M2-like TAMs can effectively stop tumor growth, metastasis, and overcome tumor drug resistance.

What problem does this paper attempt to address?

The paper attempts to address the issue of tumor drug resistance. Specifically, it explores the role of M2-like tumor-associated macrophages (M2-like TAMs) in promoting tumor drug resistance and proposes potential therapeutic strategies targeting these cells. ### Background 1. **Tumor Drug Resistance**: Tumor drug resistance is caused by the interaction of two key factors: tumor cell heterogeneity and the immunosuppressive nature of the tumor microenvironment (TME). 2. **Role of M2-like TAMs**: M2-like TAMs play a crucial role in the tumor microenvironment, not only promoting tumor metastasis but also enhancing tumor drug resistance. ### Main Issues 1. **How M2-like TAMs Promote Tumor Drug Resistance**: - By regulating signaling pathways such as PI3K/Akt, JAK/STAT, and MAPK, M2-like TAMs enhance the drug resistance of cancer cells. - For example, M2-like TAMs promote endocrine resistance by secreting CCL2 to activate the PI3K/Akt/mTOR signaling pathway; they also promote Tamoxifen resistance in breast cancer cells by activating the EGFR/PI3K/Akt signaling pathway. 2. **Therapeutic Strategies Targeting M2-like TAMs**: - The paper summarizes emerging therapeutic strategies targeting M2-like TAMs, including clinical trials combining them with traditional anti-tumor drugs. - It also analyzes methods for developing new drugs to target M2-like TAMs, aiming to effectively inhibit tumor growth, metastasis, and overcome tumor drug resistance. ### Objectives - **Understanding Mechanisms**: To elucidate the specific mechanisms by which M2-like TAMs promote tumor drug resistance in detail. - **Developing Strategies**: To propose and evaluate therapeutic strategies targeting M2-like TAMs to overcome tumor drug resistance and improve tumor treatment efficacy. Through these studies, the paper hopes to provide new insights and methods for the clinical management and treatment of tumor drug resistance.

Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy.

Targeting tumor-associated macrophages to reverse antitumor drug resistance

Targeting tumor-associated macrophages for cancer treatment

Anti-tumour strategies aiming to target tumour-associated macrophages.

Targeting tumor-associated macrophages to synergize tumor immunotherapy

Targeting Tumor-Associated Macrophages As an Antitumor Strategy.

Nanoparticles targeting tumor-associated macrophages: A novel anti-tumor therapy

Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer

Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review)

Potential therapeutic targets in myeloid cell therapy for overcoming chemoresistance and immune suppression in gastrointestinal tumors

The promising role of tumor-associated macrophages in the treatment of cancer

Tumor-associated macrophages in non-small-cell lung cancer: from treatment resistance mechanisms to therapeutic targets

Novel insights into immune cells modulation of tumor resistance

Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy

The Role of TAMs in the Regulation of Tumor Cell Resistance to Chemotherapy

Targeted Drug Nanodelivery and Immunotherapy for Combating Tumor Resistance

Tumor-Associated Macrophages: Recent Insights and Therapies

Tumor-associated macrophages within the immunological milieu: An emerging focal point for therapeutic intervention

The tumor microenvironment: a key player in multidrug resistance in cancer